Craig C Parker's Net Worth
$315 Thousand
Who is Craig C Parker?
Craig C Parker does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include GERON CORP, Surrozen, Inc./DE, vTv Therapeutics Inc., and HUMAN GENOME SCIENCES INC.
SEC CIK
Craig C Parker's CIK is 0001526064
Past Insider Trading and Trends
2022 was Craig C Parker's most active year for acquiring shares with 6 total transactions. Craig C Parker's most active month to acquire stocks was the month of September. 2022 was Craig C Parker's most active year for disposing of shares, totalling 4 transactions. Craig C Parker's most active month to dispose stocks was the month of September. 2017 saw Craig C Parker paying a total of $79,650.00 for 15,000 shares, this is the most they've acquired in one year. In 2012 Craig C Parker cashed out on 54,000 shares for a total of $769,500.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
GERON CORP (GERN) Snapshot price: $1.905
EVP, Corp Dev & Sci Affairs
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Surrozen, Inc./DE (SRZN) Snapshot price: $9.51
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 24
| |||
Form 4
|
∞
| 1.47K |
—
|
—
| 1.47K |
Apr 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
|
∞
| 2.05K |
$5.67 | $11,600.82 | 2.05K |
Dec 15
| |||
Form 4
| +261.01% | 25K |
$0.38 | $9,500.00 | 34.58K |
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
∞
| 9.58K |
$0.41 | $3,926.98 | 9.58K |
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
vTv Therapeutics Inc. (VTVT) Snapshot price: $9.89
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HUMAN GENOME SCIENCES INC No price found
Sr VP Strategy and Corporate D
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 8
| |||
| No matching records found | |||||||||